California girl, 1, diagnosed with ‘childhood Alzheimer’s’


  • Marian McGlocklin, one, said her first words at seven months but soon stopped
  • Parents Sara and Paul, from California, grew concerned about their daughter 
  • The toddler was diagnosed with a condition known as childhood Alzheimer’s
  • There is no cure for the terminal condition but Sara and Paul remain hopeful 

Stephanie Linning for MailOnline

View
comments

A couple have shared their heartbreak after their toddler daughter was diagnosed with a terminal condition known as ‘childhood Alzheimer’s’.

Parents Sara and Paul McGlocklin, from California, grew concerned after their one-year-old daughter Marian started to forget how to say her first words, like ‘hi’ and ‘bye’.

After several months, the toddler was diagnosed with Niemann-Pick disease type C (NPC), a rare disease which causes mental and physical deterioration similar to Alzheimer’s. 

Scroll down for video 

Difficult journey: Paul and Sara McGlocklin with daughters Emily, four, left, and Marian, one

Optimistic: Mother-of-two Sara is hopeful her daughter Marian, right and left with sister Emily, could be one of the first children to survive Niemann-Pick disease type C

Devastating signs: Marian learned how to talk but later forgot how to say her first words

There is currently no cure for the condition and most cases are fatal. However Marian is undergoing investigative treatment to improve her quality of life and has since started to remember words and actions she had previously forgotten. 

Sara said without the treatment Marian ‘would likely die’. She continued: ‘Marian is the youngest patient in the entire world to be receiving it, we are not 100 per cent sure what to expect but at the moment it seems to be working.

‘After her last round she seemed stronger than ever and a few days later she took her first steps.

‘About a year ago I didn’t know if she’d ever be able to crawl, it felt so far away, so to see her starting to take steps today truly feels like a dream come true.’

The family are now hoping to raise awareness and funds to aid research before Marian loses the ability to move, eat, speak and even breathe. 

Chidren’s attorney Sara, 34, and Paul, 33, who also have a four-year-old daughter, Emily, noticed Marian was not reaching developmental milestones on time. 

Diagnosis: Marian underwent tests before being diagnosed with the incurable Niemann-Pick disease type C, which causes mental and physical deterioration similar to Alzheimer’s 

Grateful: Mother Sara, pictured with Marian in hospital, said her daughter was fortunate to be receiving the investigative treatment and said without it she would ‘likely die’

Sara said: ‘When she was around nine months old she learnt how to say “hi” and “bye” but suddenly one day stopped saying them regularly. Paul and I noticed this happening on a few occasions with new words or actions that she learnt.’

Sara said doctors at first insisted there was ‘nothing wrong’ and it rook seven months before Marian was diagnosed with NPC in February. 

Sara continued: ‘Receiving the news that Marian has NPC was devastating and we want to do everything we can to help her survive it.’

Niemann-Pick type C affects fewer than 3,000 children worldwide and sufferers rarely live past the age of 10. Symptoms can include enlarged organs, loss of balance, muscle stiffness, dementia and difficulty speaking.

Developmental delays: Sara and Paul noticed Marian, pictured, was not reaching milestones

Concern: Four-year-old Emily, left with Marian, also had to undergo tests for NPC but the results were negative

In most cases children develop normally in their early years before slowly losing the ability to walk and talk. However Marian was born with the developmental delays and so her progress has been ‘really slow in some areas’, Sara said. 

She continued: ‘She remembers who we are and doesn’t have any of the advanced symptoms just yet, but she does have a few early symptoms including forgetfulness.’

Weeks after Marian’s diagnosis, Sara and Paul were told about a clinical trial in Chicago that could stabilise the devastating condition.

While Marian is too young to be enrolled onto the trial, she is eligible for compassionate use of the drug Cyclodextrin (VTS 270). 

Early signs: Marian still remembers her parents, pictured, but does suffer from forgetfulness

Lease of life: Since starting a course of investigative treatment, Marian, pictured, has started to remember words and actions she had previously forgotten

Sara said: ‘Since February she has had five rounds, we have to fly to Chicago each time where the drug is administered by a lumber puncture. 

‘Over the past few months she has really come to life, I didn’t realise some of the things that she loved until she started the treatment.

‘Marian is starting to remember the things she had previously stopped doing. And she is now using signs that she has learnt several times a day whereas before she would only remember them every couple of days.’ 

The family has set up a fundraising page to cover medical expenses.

Fundraising: Sara and Paul are raising money to pay for Marian’s medical expenses

Gratitude: Sara said the family are ‘deeply grateful’ for each of Marian’s milestones. Pictured, Marian, right, with her four-year-old sister, Emily 

She added: ‘Everything Marian does is something we are deeply grateful for, each milestone she reaches is something that I feared she would never be able to do.

‘The treatment she is undergoing isn’t a cure, but hopefully due to medical advances she could be one of the first of her generation to survive the disease.

‘NPC is extremely underdiagnosed and we hope that more awareness will help to fight this awful disease.’

For more information visit: https://www.gofundme.com/hopeformarian  

Comments 0

Share what you think

No comments have so far been submitted. Why not be the first to send us your thoughts,
or debate this issue live on our message boards.

Close

Your comment will be posted to MailOnline as usual.

 

Close

Your comment will be posted to MailOnline as usual

We will automatically post your comment and a link to the news story to your Facebook timeline at the same time it is posted on MailOnline. To do this we will link your MailOnline account with your Facebook account. We’ll ask you to confirm this for your first post to Facebook.

You can choose on each post whether you would like it to be posted to Facebook. Your details from Facebook will be used to provide you with tailored content, marketing and ads in line with our Privacy Policy.